Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus etomidate vs etomidate for intravenous anesthesia in elderly surgical patients
ChiCTR2300071682Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Overall incidence of intraoperative and postoperative complications. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2300071682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071682.